Expression of Organic Anion Transporting Polypeptide 1c1 and Monocarboxylate Transporter 8 in the Rat Placental Barrier and the Compensatory Response to Thyroid Dysfunction
Thyroid hormones (THs) must pass from mother to fetus for normal fetal development and require the expression of placental TH transporters. We investigate the compensatory effect of placental organic anion transporting polypeptide 1c1 (Oatp1c1) and monocarboxylate transporter 8 (Mct8) on maternal thyroid dysfunction. We describe the expressions of these two transporters in placental barriers and trophoblastic cell populations in euthyroidism and thyroid dysfunction resulting from differential iodine nutrition at gestation day (GD) 16 and 20, that is, before and after the onset of fetal thyroid function. Immunohistochemistry revealed that in the blood-placenta barrier, these two TH transporters were strongly expressed in the villous interstitial substance and were weakly expressed in trophoblast cells. Levels of Oatp1c1 protein obviously increased in the placental fetal portion during maternal thyroid deficiency at GD16. Under maternal thyroid deficiency after the production of endogenous fetal TH, quantitative PCR analysis revealed down-regulation of Oatp1c1 occurred along with up-regulation of Mct8 in trophoblast cell populations isolated by laser capture microdissection (LCM); this was consistent with the protein levels in the fetal portion of the placenta. In addition, decreased D3 mRNA at GD16 and increased D2 mRNA on two gestational days were observed in trophoblast cells with thyroid dysfunction. However, levels of Oatp1c1 mRNA at GD16 and D3 mRNA at GD20 were too low to be detectable in trophoblast cells. In conclusion, placental Oatp1c1 plays an essential compensatory role when the transplacental passage of maternal THs is insufficient at the stage before the fetal TH production. In addition, the coordinated effects of Oatp1c1, Mct8, D2 and D3 in the placental barrier may regulate both transplacental TH passage and the development of trophoblast cells during thyroid dysfunction throughout the pregnancy.
References
[1]
Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, et al. (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341: 549–555.
[2]
Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, et al. (2003) Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 59: 282–288.
[3]
Morreale de Escobar G, Obregon MJ, Escobar del Rey F (2004) Role of thyroid hormone during early brain development. Eur J Endocrinol 151 Suppl 3U25–37.
[4]
Kooistra L, Crawford S, van Baar AL, Brouwers EP, Pop VJ (2006) Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 117: 161–167.
[5]
Williams GR (2008) Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 20: 784–794.
[6]
James SR, Franklyn JA, Kilby MD (2007) Placental transport of thyroid hormone. Best Pract Res Clin Endocrinol Metab 21: 253–264.
[7]
Lavado-Autric R, Auso E, Garcia-Velasco JV, Arufe Mdel C, Escobar del Rey F, et al. (2003) Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 111: 1073–1082.
[8]
Auso E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale De Escobar G, et al. (2004) A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 145: 4037–4047.
[9]
Cuevas E, Auso E, Telefont M, Morreale de Escobar G, Sotelo C, et al. (2005) Transient maternal hypothyroxinemia at onset of corticogenesis alters tangential migration of medial ganglionic eminence-derived neurons. Eur J Neurosci 22: 541–551.
[10]
Landers KA, McKinnon BD, Li H, Subramaniam VN, Mortimer RH, et al. (2009) Carrier-mediated thyroid hormone transport into placenta by placental transthyretin. J Clin Endocrinol Metab 94: 2610–2616.
[11]
Oki N, Matsuo H, Nakago S, Murakoshi H, Laoag-Fernandez JB, et al. (2004) Effects of 3,5,3'-triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts. J Clin Endocrinol Metab 89: 5213–5221.
[12]
Barber KJ, Franklyn JA, McCabe CJ, Khanim FL, Bulmer JN, et al. (2005) The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. J Clin Endocrinol Metab 90: 1655–1661.
[13]
Mortimer RH, Galligan JP, Cannell GR, Addison RS, Roberts MS (1996) Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination. J Clin Endocrinol Metab 81: 2247–2249.
[14]
Patel J, Landers K, Li H, Mortimer RH, Richard K (2011) Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol Metab 22: 164–170.
[15]
Visser WE (2008) Thyroid hormone transport in and out of cells. Trends Endocrinol. Metab 19: 50–56.
[16]
Hennemann G (2001) Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr. Rev 22: 451–476.
[17]
Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, et al. (2003) Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278: 40128–40135.
[18]
Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, et al. (2004) Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364: 1435–1437.
[19]
Sato K, Sugawara J, Sato T, Mizutamari H, Suzuki T, et al. (2003) Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta 24: 144–148.
[20]
Chan SY, Franklyn JA, Pemberton HN, Bulmer JN, Visser TJ, et al. (2006) Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol 189: 465–471.
[21]
Loubiere LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, et al. (2010) Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta 31: 295–304.
[22]
Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, et al. (2003) Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem 278: 43489–43495.
[23]
Tohyama K, Kusuhara H, Sugiyama Y (2004) Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 145: 4384–4391.
[24]
Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S (2006) Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147: 4036–4043.
[25]
Loubiere LS, Vasilopoulou E, Glazier JD, Taylor PM, Franklyn JA, et al. (2012) Expression and function of thyroid hormone transporters in the microvillous plasma membrane of human term placental syncytiotrophoblast. Endocrinology 153: 6126–6135.
[26]
Vasilopoulou E, Loubiere LS, Heuer H, Trajkovic-Arsic M, Darras VM, et al. (2013) Monocarboxylate transporter 8 modulates the viability and invasive capacity of human placental cells and fetoplacental growth in mice. PLoS One 8: e65402.
[27]
Morreale de Escobar G, Pastor R, Obregon MJ, Escobar del Rey F (1985) Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology 117: 1890–1900.
[28]
Jooste PL, Strydom E (2010) Methods for determination of iodine in urine and salt. Best Pract Res Clin Endocrinol Metab 24: 77–88.
[29]
Zhang L, Sun YN, Li YM, Lin LX, Ye Y, et al. (2011) Effect of different iodine nutrition on cerebellum Pcp-2 in rat offspring during lactation. Biol Trace Elem Res 143: 1629–1639.
[30]
Akanuma S, Hirose S, Tachikawa M, Hosoya K (2013) Localization of organic anion transporting polypeptide (Oatp) 1a4 and Oatp1c1 at the rat blood-retinal barrier. Fluids Barriers CNS 10: 29.
[31]
Przybyla-Zawislak BD, Thorn BT, Ali SF, Dennis RA, Amato A, et al. (2005) Identification of rat hippocampal mRNAs altered by the mitochondrial toxicant, 3-NPA. Ann N Y Acad Sci 1053: 162–173.
[32]
Silvestri E, Lombardi A, de Lange P, Schiavo L, Lanni A, et al. (2008) Age-related changes in renal and hepatic cellular mechanisms associated with variations in rat serum thyroid hormone levels. Am J Physiol Endocrinol Metab 294: E1160–1168.
[33]
Ramakers C, Ruijter JM, Deprez RH, Moorman AF (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62–66.
[34]
Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, et al. (2008) Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149: 6251–6261.
[35]
Grijota-Martinez C, Diez D, Morreale de Escobar G, Bernal J, Morte B (2011) Lack of action of exogenously administered T3 on the fetal rat brain despite expression of the monocarboxylate transporter 8. Endocrinology 152: 1713–1721.
[36]
Tamai I, Nezu J, Uchino H, Sai Y, Oku A, et al. (2000) Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun 273: 251–260.
[37]
Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, et al. (2002) Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 16: 2283–2296.
[38]
Svoboda M, Riha J, Wlcek K, Jaeger W, Thalhammer T (2011) Organic anion transporting polypeptides (OATPs): regulation of expression and function. Curr Drug Metab 12: 139–153.
[39]
Kogai T, Liu YY, Richter LL, Mody K, Kagechika H, et al. (2010) Retinoic acid induces expression of the thyroid hormone transporter, monocarboxylate transporter 8 (Mct8). J Biol Chem 285: 27279–27288.
[40]
Chen ZP, Hetzel BS (2010) Cretinism revisited. Best Pract Res Clin Endocrinol Metab 24: 39–50.
[41]
Babu S, Sinha RA, Mohan V, Rao G, Pal A, et al. (2010) Effect of hypothyroxinemia on thyroid hormone responsiveness and action during rat postnatal neocortical development. Exp Neurol 228: 91–98.
[42]
Morreale de Escobar G, Obregon MJ, Escobar del Rey F (2000) Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85: 3975–3987.
[43]
Baumann NA, Gronowski AM (2007) Establishment of reference intervals for thyroid- stimulating hormone and free thyroxine in amniotic fluid using the Bayer ADVIA Centaur. Am J Clin Pathol 128: 158–163.
[44]
Luton D, Huel C, Vuillard E, Leguy MC, Tsatsaris V, et al. (2009) [Assessment of thyroid hormones and androgens in amniotic fluid: clinical interest]. Ann Biol Clin (Paris) 67: 299–305.
[45]
Kinne A, Schulein R, Krause G (2011) Primary and secondary thyroid hormone transporters. Thyroid Res 4 Suppl 1S7.
[46]
Hagenbuch B (2007) Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab 21: 209–221.
[47]
Hennemann G, Krenning EP, Polhuys M, Mol JA, Bernard BF, et al. (1986) Carrier-mediated transport of thyroid hormone into rat hepatocytes is rate-limiting in total cellular uptake and metabolism. Endocrinology 119: 1870–1872.
[48]
Capelo LP, Beber EH, Fonseca TL, Gouveia CH (2009) The monocarboxylate transporter 8 and L-type amino acid transporters 1 and 2 are expressed in mouse skeletons and in osteoblastic MC3T3-E1 cells. Thyroid 19: 171–180.
[49]
Mayerl S, Visser TJ, Darras VM, Horn S, Heuer H (2012) Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain. Endocrinology 153: 1528–1537.
[50]
de Escobar GM, Obregon MJ, del Rey FE (2004) Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 18: 225–248.
[51]
Costa A, Arisio R, Benedetto C, Bertino E, Fabris C, et al. (1991) Thyroid hormones in tissues from human embryos and fetuses. J Endocrinol Invest 14: 559–568.
[52]
Calvo RM, Jauniaux E, Gulbis B, Asuncion M, Gervy C, et al. (2002) Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87: 1768–1777.
[53]
Yoshida K, Suzuki M, Sakurada T, Shinkawa O, Takahashi T, et al. (1985) Human placental thyroxine inner ring monodeiodinase in complicated pregnancy. Metabolism 34: 535–538.
[54]
Emerson CH, Bambini G, Alex S, Castro MI, Roti E, et al. (1988) The effect of thyroid dysfunction and fasting on placenta inner ring deiodinase activity in the rat. Endocrinology 122: 809–816.
[55]
Burmeister LA, Pachucki J, St Germain DL (1997) Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138: 5231–5237.
[56]
Friedrichsen S, Christ S, Heuer H, Schafer MK, Mansouri A, et al. (2003) Regulation of iodothyronine deiodinases in the Pax8-/- mouse model of congenital hypothyroidism. Endocrinology 144: 777–784.
[57]
Vulsma T, Gons MH, de Vijlder JJ (1989) Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 321: 13–16.
[58]
Chan SY, Vasilopoulou E, Kilby MD (2009) The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab 5: 45–54.
